STOCK TITAN
  1. Home
  2. News
  3. GOVXW

CORRECTION - Aura FAT Projects Acquisition Corp. Announces Closing of Initial Public Offering and Exercise of Full Over-Allotment Option

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
IPO offering acquisition

Singapore, April 18, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire--In a release issued under the same headline on Monday, April 18th at 1:55 ET by GeoVax, Inc., please note that the release was distributed under the incorrect source and should have been sourced to Aura FAT Projects Acquisition Corp.

info@newmediawire.com


Stock GOVXW logo
Geovax Labs Inc

NASDAQ:GOVXW

GOVXW Rankings

N/A Ranked by Market Cap
N/A Ranked by Stock Gains
N/A Ranked by Dividends

GOVXW Latest News

Apr 4, 2024
GeoVax Presents Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine
Mar 28, 2024
GeoVax to Present Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine, at the World Vaccine Congress
Mar 12, 2024
GeoVax to Present at the 36th Annual Roth Conference
Mar 6, 2024
GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System
Feb 29, 2024
GeoVax Reports 2023 Year-End Financial Results and Provides Business Update

GOVXW Stock Data

Research and Development in Biotechnology
Professional, Scientific, and Technical Services
Link
Health Technology, Biotechnology
US
Smyrna

About GOVXW

geovax labs, inc., (otcqb: govx) is a clinical-stage biotechnology company developing human vaccines against infectious diseases using our modified vaccinia ankara - virus-like particle (mva-vlp) vaccine platform. our development programs are focused on preventive vaccines against hiv, zika virus, hemorrhagic fever viruses (ebola, sudan, marburg, and lassa), and malaria, as well as therapeutic vaccines for chronic hepatitis b infections and cancers. our mva-vlp platform supports in vivo production of non-infectious vlps from the cells of the very person receiving the vaccine, mimicking a natural infection, and stimulating both the humoral and cellular arms of the immune system to recognize, prevent, and control the target infection. for more information, visit www.geovax.com.